Recent neuropathological findings in MS--implications for diagnosis and therapy

Hans Lassmann1

  • 1Brain Research Institute, University of Vienna, Division of Neuroimmunology, Spitalgasse 4, 1090, Vienna, Austria. hans.lassmann@univie.ac.at

Journal of Neurology
|September 21, 2004
PubMed

Insights

Multiple sclerosis (MS) involves central nervous system inflammation and myelin destruction. Identifying diverse damage pathways is crucial for effective diagnosis and treatment of this complex neurological disease.

Area of Science:

  • Neuroimmunology
  • Neuropathology

Background:

  • Multiple sclerosis (MS) is a chronic central nervous system inflammatory disease.
  • MS primarily targets myelin sheaths, but also causes axonal injury.
  • Neurological deficits in MS can be reversible (demyelination) or irreversible (axonal loss).

Purpose of the Study:

  • To elucidate the complex and heterogeneous mechanisms of tissue injury in MS.
  • To highlight the importance of identifying distinct pathogenetic pathways in MS patients.
  • To underscore the critical role of paraclinical markers for diagnosis and therapeutic management.

Main Methods:

  • The study reviews existing literature on MS pathogenesis.
  • Mechanisms discussed include T-lymphocyte cytotoxicity, antibody and complement involvement, and macrophage-derived toxins.
  • Genetic susceptibility to immune-mediated damage is also considered.

Main Results:

  • Tissue injury in MS results from a combination of immune-mediated attacks.
  • Axonal destruction, beyond a certain threshold, leads to permanent neurological deficits.
  • Individual variations in pathogenetic pathways exist among MS patients.

Conclusions:

  • Understanding the diverse mechanisms of demyelination and tissue damage is vital.
  • Paraclinical markers are essential for personalized diagnosis and treatment strategies in MS.
  • Targeting specific pathogenetic pathways may improve therapeutic outcomes.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...